董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Debra L. Morris | 女 | Independent Director | 67 | 32.67万 | 32.98 | 2026-06-08 |
| Richard R. Barrera | 男 | Independent Director | 54 | 未披露 | 478.60 | 2026-06-08 |
| Bret Christensen | 男 | Director | 55 | 501.73万 | 50.63 | 2026-06-08 |
| Marc Beer | 男 | Executive Chairman and Director | 61 | 140.68万 | 419.81 | 2026-06-08 |
| Robert Peterson | 男 | Chief Financial Officer and Chief Business Officer and Interim Chief Executive Officer and Director | 49 | 145.45万 | 32.81 | 2026-06-08 |
| Dana Jacoby | 女 | Independent Director | 51 | 32.74万 | 33.39 | 2026-06-08 |
| S. Mark Cone | 男 | Independent Director | 63 | 31.34万 | 44.75 | 2026-06-08 |
| Andrew R. Heyer | 男 | Independent Director | 68 | 32.39万 | 280.57 | 2026-06-08 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Marc Beer | 男 | Executive Chairman and Director | 61 | 140.68万 | 419.81 | 2026-06-08 |
| Robert Peterson | 男 | Chief Financial Officer and Chief Business Officer and Interim Chief Executive Officer and Director | 49 | 145.45万 | 32.81 | 2026-06-08 |
董事简历
中英对照 | 中文 | 英文- Debra L. Morris
-
DebraL.Morris自2013年3月以来一直担任我们首席财务官的执行Vice President。在加入该公司之前，莫里斯女士于2010年2月至2013年2月担任Sitel Worldwide Corporation的美洲首席财务官。在此之前，她从2004年到2010年担任Tatum LLC的合伙人，从2008年到2010年担任董事，并为与Tatum LLC签约的公司提供临时和永久首席财务官服务，包括LifeMasters Supported SelfCare和Reladyne。从1999年到2002年，她是口径碰撞中心的首席财务官。莫里斯女士职业生涯的早期在世邦魏理仕（CB Richard Ellis）担任越来越负责任的职务，包括执行Vice President-全球营销和整合以及执行Vice President-全球首席会计官。莫里斯女士目前担任雷克斯工业房地产公司董事会成员。Morris女士拥有新罕布什尔州新伦敦Colby Sawyer College工商管理学士学位。
Debra L. Morris,has served as a member of Biote Corp. Board since November 2022. Ms. Morris serves as Executive Advisor to AccessHope, LLC, and previously served as its President from November 2024 through December 2025 and as its Chief Financial Officer and Chief Operating Officer from May 2024 to November 2024. Previously, Ms. Morris served as the executive vice president and chief financial officer of Apria, Inc. (Nasdaq: APR) from March 2013 through October 2022. Prior to that, Ms. Morris served as chief financial officer of Americas for Sitel Worldwide Corporation from February 2010 to February 2013. Prior to that, she served as a partner of Tatum LLC from 2004 to 2010 and as a director from 2008 to 2010 and provided interim and permanent chief financial officer services. From May 2020 to February 2024, Ms. Morris served as a director for Alternative Logistics Technologies, Holdco, LLC (a.k.a EverDriven) where she served as the chair of the audit committee. Since December 2020, Ms. Morris serves as a director of Rexford Industrial (NYSE: REXR) and serves on the compensation and nomination and governance committees. Since January 2025, Ms. Morris serves as a director of Progyny, Inc. (Nasdaq: PGNY) and serves on the audit committee. Ms. Morris holds a B.S. in Business Administration from Colby Sawyer College in New London, New Hampshire. - DebraL.Morris自2013年3月以来一直担任我们首席财务官的执行Vice President。在加入该公司之前，莫里斯女士于2010年2月至2013年2月担任Sitel Worldwide Corporation的美洲首席财务官。在此之前，她从2004年到2010年担任Tatum LLC的合伙人，从2008年到2010年担任董事，并为与Tatum LLC签约的公司提供临时和永久首席财务官服务，包括LifeMasters Supported SelfCare和Reladyne。从1999年到2002年，她是口径碰撞中心的首席财务官。莫里斯女士职业生涯的早期在世邦魏理仕（CB Richard Ellis）担任越来越负责任的职务，包括执行Vice President-全球营销和整合以及执行Vice President-全球首席会计官。莫里斯女士目前担任雷克斯工业房地产公司董事会成员。Morris女士拥有新罕布什尔州新伦敦Colby Sawyer College工商管理学士学位。
- Debra L. Morris,has served as a member of Biote Corp. Board since November 2022. Ms. Morris serves as Executive Advisor to AccessHope, LLC, and previously served as its President from November 2024 through December 2025 and as its Chief Financial Officer and Chief Operating Officer from May 2024 to November 2024. Previously, Ms. Morris served as the executive vice president and chief financial officer of Apria, Inc. (Nasdaq: APR) from March 2013 through October 2022. Prior to that, Ms. Morris served as chief financial officer of Americas for Sitel Worldwide Corporation from February 2010 to February 2013. Prior to that, she served as a partner of Tatum LLC from 2004 to 2010 and as a director from 2008 to 2010 and provided interim and permanent chief financial officer services. From May 2020 to February 2024, Ms. Morris served as a director for Alternative Logistics Technologies, Holdco, LLC (a.k.a EverDriven) where she served as the chair of the audit committee. Since December 2020, Ms. Morris serves as a director of Rexford Industrial (NYSE: REXR) and serves on the compensation and nomination and governance committees. Since January 2025, Ms. Morris serves as a director of Progyny, Inc. (Nasdaq: PGNY) and serves on the audit committee. Ms. Morris holds a B.S. in Business Administration from Colby Sawyer College in New London, New Hampshire.
- Richard R. Barrera
-
Richard R. Barrera此前是Redwood Capital Management和Glenview Capital Management两家私人投资管理公司的合伙人和联合投资组合经理。Barrera是西奈山儿童中心基金会董事会成员，也是成功学院特许学校董事会成员。
Richard R. Barrera previously was a Partner and Co-Portfolio Manager at Redwood Capital Management and Glenview Capital Management both private investment management firms.Mr. Barrera is a member of the board of Mount Sinai Children's Center Foundation and a member of the board of Success Academy Charter Schools. - Richard R. Barrera此前是Redwood Capital Management和Glenview Capital Management两家私人投资管理公司的合伙人和联合投资组合经理。Barrera是西奈山儿童中心基金会董事会成员，也是成功学院特许学校董事会成员。
- Richard R. Barrera previously was a Partner and Co-Portfolio Manager at Redwood Capital Management and Glenview Capital Management both private investment management firms.Mr. Barrera is a member of the board of Mount Sinai Children's Center Foundation and a member of the board of Success Academy Charter Schools.
- Bret Christensen
-
Bret Christensen，自2019年2月起担任Insulet Corporation执行副总裁兼首席商务官。2017年5月至2019年2月，Christensen先生担任Insulet Corporation高级副总裁兼首席商务官。2013年8月至2017年5月，Christensen先生担任Myriad Genetics, Inc.预防保健总经理。2009年至2013年7月，Christensen先生担任Hologic, Inc.销售和营销副总裁。在2009年之前，Christensen先生曾在Hologic担任多个领导职务，包括地区销售经理和区域业务总监。Christensen在Utah Valley University获得了商业管理理学学士学位，并在University of Utah获得了MBA学位。
Bret Christensen,has served as Insulet Corporation Executive Vice President and Chief Commercial Officer since February 2019. From May 2017 to February 2019,Mr. Christensen served as Insulet Corporation Senior Vice President and Chief Commercial Officer. From August 2013 to May 2017,Mr. Christensen served as General Manager of Preventive Care of Myriad Genetics,Inc. From 2009 to July 2013,Mr. Christensen served as Vice President,Sales and Marketing of Hologic,Inc. Prior to 2009,Mr. Christensen held several leadership roles at Hologic,including District Sales Manager and Regional Business Director. Mr. Christensen earned a Bachelor of Science in Business Management from Utah Valley University and received an MBA from the University of Utah. - Bret Christensen，自2019年2月起担任Insulet Corporation执行副总裁兼首席商务官。2017年5月至2019年2月，Christensen先生担任Insulet Corporation高级副总裁兼首席商务官。2013年8月至2017年5月，Christensen先生担任Myriad Genetics, Inc.预防保健总经理。2009年至2013年7月，Christensen先生担任Hologic, Inc.销售和营销副总裁。在2009年之前，Christensen先生曾在Hologic担任多个领导职务，包括地区销售经理和区域业务总监。Christensen在Utah Valley University获得了商业管理理学学士学位，并在University of Utah获得了MBA学位。
- Bret Christensen,has served as Insulet Corporation Executive Vice President and Chief Commercial Officer since February 2019. From May 2017 to February 2019,Mr. Christensen served as Insulet Corporation Senior Vice President and Chief Commercial Officer. From August 2013 to May 2017,Mr. Christensen served as General Manager of Preventive Care of Myriad Genetics,Inc. From 2009 to July 2013,Mr. Christensen served as Vice President,Sales and Marketing of Hologic,Inc. Prior to 2009,Mr. Christensen held several leadership roles at Hologic,including District Sales Manager and Regional Business Director. Mr. Christensen earned a Bachelor of Science in Business Management from Utah Valley University and received an MBA from the University of Utah.
- Marc Beer
-
自2025年7月起，Marc Beer担任非执行主席，此前曾于2022年5月至2025年7月担任执行主席，并于2021年1月至2022年5月担任控股董事会主席。Beer先生还自2020年4月起担任Origami Surgical LLC董事会主席，自2018年8月起担任LumeNXT LLC董事会主席。在此之前，Beer先生于2016年8月与他人共同创立了Renovia Inc.，此前他曾担任董事会主席和首席执行官的职务，并继续担任战略顾问。在创办Renovia Inc.之前，Beer先生于2013年12月至2018年1月担任Minerva Neurosciences, Inc.（纳斯达克：NERV）的董事会主席。Beer先生拥有迈阿密大学的学士学位。
Marc Beer,has served as the Non-executive Chairman of Biote Corp. Board since July 2025 and was previously the Executive Chairman from May 2022 to July 2025 and chairman of the board of managers of Holdings from January 2021 to May 2022. Mr. Beer has also served as the chairman of the board of Origami Surgical LLC since April 2020 and as the chairman of the board of LumeNXT LLC since August 2018. Prior to that, Mr. Beer co-founded Renovia Inc. in August 2016, where he previously held the positions of chairman of the board and chief executive officer and continues to serve as a strategic advisor. Before starting Renovia Inc., Mr. Beer was the chairman of the board of Minerva Neurosciences, Inc. (Nasdaq: NERV) from December 2013 to January 2018. Mr. Beer holds a BS from Miami University. - 自2025年7月起，Marc Beer担任非执行主席，此前曾于2022年5月至2025年7月担任执行主席，并于2021年1月至2022年5月担任控股董事会主席。Beer先生还自2020年4月起担任Origami Surgical LLC董事会主席，自2018年8月起担任LumeNXT LLC董事会主席。在此之前，Beer先生于2016年8月与他人共同创立了Renovia Inc.，此前他曾担任董事会主席和首席执行官的职务，并继续担任战略顾问。在创办Renovia Inc.之前，Beer先生于2013年12月至2018年1月担任Minerva Neurosciences, Inc.（纳斯达克：NERV）的董事会主席。Beer先生拥有迈阿密大学的学士学位。
- Marc Beer,has served as the Non-executive Chairman of Biote Corp. Board since July 2025 and was previously the Executive Chairman from May 2022 to July 2025 and chairman of the board of managers of Holdings from January 2021 to May 2022. Mr. Beer has also served as the chairman of the board of Origami Surgical LLC since April 2020 and as the chairman of the board of LumeNXT LLC since August 2018. Prior to that, Mr. Beer co-founded Renovia Inc. in August 2016, where he previously held the positions of chairman of the board and chief executive officer and continues to serve as a strategic advisor. Before starting Renovia Inc., Mr. Beer was the chairman of the board of Minerva Neurosciences, Inc. (Nasdaq: NERV) from December 2013 to January 2018. Mr. Beer holds a BS from Miami University.
- Robert Peterson
-
Robert Peterson自2024年1月起担任百奥泰首席财务官，并于2025年4月起担任首席商务官。在加入Biote之前，Peterson先生曾于2017年9月至2024年1月在全球兽医制药和健康公司Virbac S.A.的子公司Virbac Corp.担任执行副总裁兼首席财务官。Peterson先生是一名注册会计师，拥有得克萨斯基督教大学的学士学位和工商管理硕士学位。
Robert Peterson,has served as the Chief Financial Officer of Biote since January 2024 and also became the Chief Business Officer in April 2025. Prior to joining Biote, Mr. Peterson served as the executive vice president and chief financial officer at Virbac Corp., a subsidiary of Virbac S.A., a global veterinary pharmaceutical and wellness company, from September 2017 to January 2024. Mr. Peterson is a Certified Public Accountant and holds a B.B.A. and an M.B.A. from the Texas Christian University. - Robert Peterson自2024年1月起担任百奥泰首席财务官，并于2025年4月起担任首席商务官。在加入Biote之前，Peterson先生曾于2017年9月至2024年1月在全球兽医制药和健康公司Virbac S.A.的子公司Virbac Corp.担任执行副总裁兼首席财务官。Peterson先生是一名注册会计师，拥有得克萨斯基督教大学的学士学位和工商管理硕士学位。
- Robert Peterson,has served as the Chief Financial Officer of Biote since January 2024 and also became the Chief Business Officer in April 2025. Prior to joining Biote, Mr. Peterson served as the executive vice president and chief financial officer at Virbac Corp., a subsidiary of Virbac S.A., a global veterinary pharmaceutical and wellness company, from September 2017 to January 2024. Mr. Peterson is a Certified Public Accountant and holds a B.B.A. and an M.B.A. from the Texas Christian University.
- Dana Jacoby
-
达纳 Jacoby自2022年5月起担任董事会成员，自2021年8月起担任Holdings的董事会成员。Jacoby女士此前曾于2015年11月至2020年12月担任Specialty Networks Consulting的首席执行官。2017年10月，Jacoby女士创立了Vector Medical Group，并继续担任首席执行官。Jacoby女士拥有商业和医疗保健硕士学位、新泽西州医学和牙科大学罗伯特伍德约翰逊医学院卫生系统硕士学位以及路易斯安那州立大学政治学和公共关系学士学位。
Dana Jacoby,has served as a member of Biote Corp. Board since May 2022 and as a member of the board of managers of Holdings since August 2021. Ms. Jacoby previously served as the chief executive officer of Specialty Networks Consulting from November 2015 to December 2020. In October 2017, Ms. Jacoby founded Vector Medical Group, where she continues to serve as chief executive officer. Ms. Jacoby holds an M.S. in Business and Healthcare, Master of Health Systems from the Robert Wood Johnson Medical School at the University of Medicine and Dentistry of New Jersey and a B.S. in Political Science and Public Relations from Louisiana State University. - 达纳 Jacoby自2022年5月起担任董事会成员，自2021年8月起担任Holdings的董事会成员。Jacoby女士此前曾于2015年11月至2020年12月担任Specialty Networks Consulting的首席执行官。2017年10月，Jacoby女士创立了Vector Medical Group，并继续担任首席执行官。Jacoby女士拥有商业和医疗保健硕士学位、新泽西州医学和牙科大学罗伯特伍德约翰逊医学院卫生系统硕士学位以及路易斯安那州立大学政治学和公共关系学士学位。
- Dana Jacoby,has served as a member of Biote Corp. Board since May 2022 and as a member of the board of managers of Holdings since August 2021. Ms. Jacoby previously served as the chief executive officer of Specialty Networks Consulting from November 2015 to December 2020. In October 2017, Ms. Jacoby founded Vector Medical Group, where she continues to serve as chief executive officer. Ms. Jacoby holds an M.S. in Business and Healthcare, Master of Health Systems from the Robert Wood Johnson Medical School at the University of Medicine and Dentistry of New Jersey and a B.S. in Political Science and Public Relations from Louisiana State University.
- S. Mark Cone
-
S. Mark Cone自2022年5月起担任董事会成员，自2021年8月起担任Holdings的董事会成员。Cone博士还自2015年10月起担任Privia Health旗下南得克萨斯市场（纳斯达克：PRVA）的市场总裁，并自2015年10月起担任Privia Medical Group Gulf Coast总裁。此外，自2013年12月起，Cone博士担任美国妇女健康联盟董事会副总裁，并自2020年10月起担任Cedar Gate Technologies旗下公司Global Women's Health Providers董事会主席。Cone博士目前担任Fannin Surgicare（一家门诊患者ASC）的顾问委员会主席。在担任这些职务之前，Cone博士在2014年12月至2015年10月期间担任Complete MD Solutions的首席执行官，该公司是一家医生管理公司。他拥有贝勒医学院的医学博士学位和得克萨斯农工大学的生物学和医学理学学士学位。
S. Mark Cone,has served as a member of Biote Corp. Board since May 2022 and as a member of the board of managers of Holdings since August 2021. Dr. Cone has also served as the market president of Privia Health's South Texas market (Nasdaq: PRVA) since October 2015 and as the president of Privia Medical Group Gulf Coast since October 2015. Additionally, since December 2013, Dr. Cone has served as vice president of the board of directors of the U.S. Women's Health Alliance and as chairman of the board of Global Women's Health Providers, a Cedar Gate Technologies company, since October 2020. Dr. Cone currently serves as chairman of the advisory board for Fannin Surgicare, an outpatient ASC. Prior to these positions, Dr. Cone was the chief executive officer of Complete MD Solutions, a physician management company from December 2014 to October 2015. He holds an M.D. from Baylor College of Medicine and a Bachelor of Science in Biology and Medicine from Texas A&M University. - S. Mark Cone自2022年5月起担任董事会成员，自2021年8月起担任Holdings的董事会成员。Cone博士还自2015年10月起担任Privia Health旗下南得克萨斯市场（纳斯达克：PRVA）的市场总裁，并自2015年10月起担任Privia Medical Group Gulf Coast总裁。此外，自2013年12月起，Cone博士担任美国妇女健康联盟董事会副总裁，并自2020年10月起担任Cedar Gate Technologies旗下公司Global Women's Health Providers董事会主席。Cone博士目前担任Fannin Surgicare（一家门诊患者ASC）的顾问委员会主席。在担任这些职务之前，Cone博士在2014年12月至2015年10月期间担任Complete MD Solutions的首席执行官，该公司是一家医生管理公司。他拥有贝勒医学院的医学博士学位和得克萨斯农工大学的生物学和医学理学学士学位。
- S. Mark Cone,has served as a member of Biote Corp. Board since May 2022 and as a member of the board of managers of Holdings since August 2021. Dr. Cone has also served as the market president of Privia Health's South Texas market (Nasdaq: PRVA) since October 2015 and as the president of Privia Medical Group Gulf Coast since October 2015. Additionally, since December 2013, Dr. Cone has served as vice president of the board of directors of the U.S. Women's Health Alliance and as chairman of the board of Global Women's Health Providers, a Cedar Gate Technologies company, since October 2020. Dr. Cone currently serves as chairman of the advisory board for Fannin Surgicare, an outpatient ASC. Prior to these positions, Dr. Cone was the chief executive officer of Complete MD Solutions, a physician management company from December 2014 to October 2015. He holds an M.D. from Baylor College of Medicine and a Bachelor of Science in Biology and Medicine from Texas A&M University.
- Andrew R. Heyer
-
Andrew R. Heyer自2020年12月BINES组合关闭以来一直担任ARKO母公司的董事，并自2023年6月起担任ARKO母公司的首席独立董事。他还曾担任Haymaker Acquisition Corp. II（“Haymaker”）的总裁和董事，该公司自上述BINEY组合成立以来一直担任该公司的总裁和董事。Heyer先生是一位金融专业人士，在消费和服务行业投资方面拥有40多年的经验，他曾为大型私募股权公司提供杠杆融资策略方面的建议。Heyer先生在2019年3月OneSpaWorld Holdings（纳斯达克股票代码：OSW）（“OneSpaWorld”）合并之前曾是Haymaker Acquisition Corp. I（“Haymaker I”）的高级职员和董事，并继续在董事会任职。Heyer先生在2022年5月Haymaker Acquisition Corp. III（“Haymaker III”）与预防性医疗保健提供商biote，Corp.（纳斯达克股票代码：BTMD）合并之前曾是该公司的高级职员和董事，自那时起他一直在董事会任职。自2010年起，Heyer先生还担任技术前沿家具品牌零售商The Lovesac Company（NASDAQ：LOVE）的董事会成员。Heyer先生是Mistral Equity Partners的首席执行官和创始人，Mistral Equity Partners是一家成立于2007年的私募股权基金，投资于消费行业。在2007年创立Mistral之前，从2000年到2007年，Heyer先生担任Trimaran Capital Partners的创始管理合伙人，这是一家价值13亿美元的私募股权基金。Heyer先生曾担任CIBC World Markets Corp.的副董事长，并在1995年至2001年期间担任CIBC Argosy Merchant Banking Funds的联席主管。在1995年加入CIBC World Markets Corp.之前，Heyer先生曾于1990年至1995年担任Argosy Group L.P.的创始人和董事总经理。从1984年到1990年，Heyer先生在Drexel Burnham Lambert Inc.担任董事总经理，在此之前，他曾在Shearson/美国运通工作。
Andrew R. Heyer,has served as a member of Biote Corp. Board since May 2022. Mr. Andrew Heyer previously served as the president and director of HYAC from July 2020 until HYAC completed its business combination in May 2022, and is a finance professional with over 40 years of experience investing in the consumer and consumer-related products and services industries, as well as a senior banker in leveraged finance during which time his clients included many large private equity firms. Mr. Andrew Heyer served as president and director of Haymaker II until it completed its business combination in December 2020 with GPM Investments, LLC ("GPM") and ARKO Holdings Ltd. ("ARKO Holdings"), which together merged under a new holding company, ARKO Corp. (Nasdaq: ARKO) as part of the business combination, and has remained on the board since such time. Mr. Andrew Heyer was president and director of Haymaker I until it completed its business combination with OneSpaWorld Holdings in March 2019, and has since remained on its board since such time. Currently, Mr. Andrew Heyer is the Chief Executive Officer and founder of Mistral Equity Partners ("Mistral"), a private equity fund manager founded in 2007 that invests in the consumer industry. Prior to founding Mistral in 2007, from 2000 to 2007, Mr. Andrew Heyer served as a Founding Managing Partner of Trimaran Capital Partners, a $1.3 billion private equity fund. Mr. Andrew Heyer was formerly a vice chairman of CIBC World Markets Corp. and a co-head of the CIBC Argosy Merchant Banking Funds from 1995 to 2001. Prior to joining CIBC World Markets Corp. in 1995, Mr. Andrew Heyer was a founder and Managing Director of The Argosy Group L.P. ("Argosy") from 1985 to 1995. Before Argosy, from 1984 to 1985, Mr. Heyer was a Managing Director at Drexel Burnham Lambert Incorporated and, previous to that, he worked at Shearson/American Express. Mr. Andrew Heyer also currently serves as vice president of Haymaker Acquisition Corp. 4 ("Haymaker 4") (NYSE: HYAC), a SPAC that has not yet completed its initial public offering. From 1993 through 2009, Mr. Andrew Heyer also served on the board of The Hain Celestial Group, Inc. (Nasdaq: HAIN), a natural and organic food and products company, rejoining the board from 2012 to April 2019. Mr. Andrew Heyer also serves on the board of several private companies owned in whole or in part by Mistral, including Worldwise, Inc., a pet accessories business from 2011 to the present, and The Lovesac Company, Inc. (Nasdaq: LOVE), a branded omni-channel retailer of technology-forward furniture, from 2010 to the present. Mr. Andrew Heyer has also served on the board of Insomnia Cookies, a retailer of desserts open primarily in the evening and nighttime, and on the investment committee of AF Ventures, an investor in high-growth consumer product companies. In the past, Mr. Andrew Heyer has served as a director of XpresSpa Group, Inc. from 2016 to 2019, Las Vegas Sands Corp., a casino company, from 2006 to 2008, El Pollo Loco Holdings, Inc., a casual Mexican restaurant, from 2005 to 2008, and Reddy Ice Holdings, Inc., a manufacturer of packaged ice products, from 2003 to 2006. Mr. Andrew Heyer received his B.Sc. and M.B.A. from the Wharton School of the University of Pennsylvania, graduating magna cum laude. - Andrew R. Heyer自2020年12月BINES组合关闭以来一直担任ARKO母公司的董事，并自2023年6月起担任ARKO母公司的首席独立董事。他还曾担任Haymaker Acquisition Corp. II（“Haymaker”）的总裁和董事，该公司自上述BINEY组合成立以来一直担任该公司的总裁和董事。Heyer先生是一位金融专业人士，在消费和服务行业投资方面拥有40多年的经验，他曾为大型私募股权公司提供杠杆融资策略方面的建议。Heyer先生在2019年3月OneSpaWorld Holdings（纳斯达克股票代码：OSW）（“OneSpaWorld”）合并之前曾是Haymaker Acquisition Corp. I（“Haymaker I”）的高级职员和董事，并继续在董事会任职。Heyer先生在2022年5月Haymaker Acquisition Corp. III（“Haymaker III”）与预防性医疗保健提供商biote，Corp.（纳斯达克股票代码：BTMD）合并之前曾是该公司的高级职员和董事，自那时起他一直在董事会任职。自2010年起，Heyer先生还担任技术前沿家具品牌零售商The Lovesac Company（NASDAQ：LOVE）的董事会成员。Heyer先生是Mistral Equity Partners的首席执行官和创始人，Mistral Equity Partners是一家成立于2007年的私募股权基金，投资于消费行业。在2007年创立Mistral之前，从2000年到2007年，Heyer先生担任Trimaran Capital Partners的创始管理合伙人，这是一家价值13亿美元的私募股权基金。Heyer先生曾担任CIBC World Markets Corp.的副董事长，并在1995年至2001年期间担任CIBC Argosy Merchant Banking Funds的联席主管。在1995年加入CIBC World Markets Corp.之前，Heyer先生曾于1990年至1995年担任Argosy Group L.P.的创始人和董事总经理。从1984年到1990年，Heyer先生在Drexel Burnham Lambert Inc.担任董事总经理，在此之前，他曾在Shearson/美国运通工作。
- Andrew R. Heyer,has served as a member of Biote Corp. Board since May 2022. Mr. Andrew Heyer previously served as the president and director of HYAC from July 2020 until HYAC completed its business combination in May 2022, and is a finance professional with over 40 years of experience investing in the consumer and consumer-related products and services industries, as well as a senior banker in leveraged finance during which time his clients included many large private equity firms. Mr. Andrew Heyer served as president and director of Haymaker II until it completed its business combination in December 2020 with GPM Investments, LLC ("GPM") and ARKO Holdings Ltd. ("ARKO Holdings"), which together merged under a new holding company, ARKO Corp. (Nasdaq: ARKO) as part of the business combination, and has remained on the board since such time. Mr. Andrew Heyer was president and director of Haymaker I until it completed its business combination with OneSpaWorld Holdings in March 2019, and has since remained on its board since such time. Currently, Mr. Andrew Heyer is the Chief Executive Officer and founder of Mistral Equity Partners ("Mistral"), a private equity fund manager founded in 2007 that invests in the consumer industry. Prior to founding Mistral in 2007, from 2000 to 2007, Mr. Andrew Heyer served as a Founding Managing Partner of Trimaran Capital Partners, a $1.3 billion private equity fund. Mr. Andrew Heyer was formerly a vice chairman of CIBC World Markets Corp. and a co-head of the CIBC Argosy Merchant Banking Funds from 1995 to 2001. Prior to joining CIBC World Markets Corp. in 1995, Mr. Andrew Heyer was a founder and Managing Director of The Argosy Group L.P. ("Argosy") from 1985 to 1995. Before Argosy, from 1984 to 1985, Mr. Heyer was a Managing Director at Drexel Burnham Lambert Incorporated and, previous to that, he worked at Shearson/American Express. Mr. Andrew Heyer also currently serves as vice president of Haymaker Acquisition Corp. 4 ("Haymaker 4") (NYSE: HYAC), a SPAC that has not yet completed its initial public offering. From 1993 through 2009, Mr. Andrew Heyer also served on the board of The Hain Celestial Group, Inc. (Nasdaq: HAIN), a natural and organic food and products company, rejoining the board from 2012 to April 2019. Mr. Andrew Heyer also serves on the board of several private companies owned in whole or in part by Mistral, including Worldwise, Inc., a pet accessories business from 2011 to the present, and The Lovesac Company, Inc. (Nasdaq: LOVE), a branded omni-channel retailer of technology-forward furniture, from 2010 to the present. Mr. Andrew Heyer has also served on the board of Insomnia Cookies, a retailer of desserts open primarily in the evening and nighttime, and on the investment committee of AF Ventures, an investor in high-growth consumer product companies. In the past, Mr. Andrew Heyer has served as a director of XpresSpa Group, Inc. from 2016 to 2019, Las Vegas Sands Corp., a casino company, from 2006 to 2008, El Pollo Loco Holdings, Inc., a casual Mexican restaurant, from 2005 to 2008, and Reddy Ice Holdings, Inc., a manufacturer of packaged ice products, from 2003 to 2006. Mr. Andrew Heyer received his B.Sc. and M.B.A. from the Wharton School of the University of Pennsylvania, graduating magna cum laude.
高管简历
中英对照 | 中文 | 英文- Marc Beer
自2025年7月起，Marc Beer担任非执行主席，此前曾于2022年5月至2025年7月担任执行主席，并于2021年1月至2022年5月担任控股董事会主席。Beer先生还自2020年4月起担任Origami Surgical LLC董事会主席，自2018年8月起担任LumeNXT LLC董事会主席。在此之前，Beer先生于2016年8月与他人共同创立了Renovia Inc.，此前他曾担任董事会主席和首席执行官的职务，并继续担任战略顾问。在创办Renovia Inc.之前，Beer先生于2013年12月至2018年1月担任Minerva Neurosciences, Inc.（纳斯达克：NERV）的董事会主席。Beer先生拥有迈阿密大学的学士学位。
Marc Beer,has served as the Non-executive Chairman of Biote Corp. Board since July 2025 and was previously the Executive Chairman from May 2022 to July 2025 and chairman of the board of managers of Holdings from January 2021 to May 2022. Mr. Beer has also served as the chairman of the board of Origami Surgical LLC since April 2020 and as the chairman of the board of LumeNXT LLC since August 2018. Prior to that, Mr. Beer co-founded Renovia Inc. in August 2016, where he previously held the positions of chairman of the board and chief executive officer and continues to serve as a strategic advisor. Before starting Renovia Inc., Mr. Beer was the chairman of the board of Minerva Neurosciences, Inc. (Nasdaq: NERV) from December 2013 to January 2018. Mr. Beer holds a BS from Miami University.- 自2025年7月起，Marc Beer担任非执行主席，此前曾于2022年5月至2025年7月担任执行主席，并于2021年1月至2022年5月担任控股董事会主席。Beer先生还自2020年4月起担任Origami Surgical LLC董事会主席，自2018年8月起担任LumeNXT LLC董事会主席。在此之前，Beer先生于2016年8月与他人共同创立了Renovia Inc.，此前他曾担任董事会主席和首席执行官的职务，并继续担任战略顾问。在创办Renovia Inc.之前，Beer先生于2013年12月至2018年1月担任Minerva Neurosciences, Inc.（纳斯达克：NERV）的董事会主席。Beer先生拥有迈阿密大学的学士学位。
- Marc Beer,has served as the Non-executive Chairman of Biote Corp. Board since July 2025 and was previously the Executive Chairman from May 2022 to July 2025 and chairman of the board of managers of Holdings from January 2021 to May 2022. Mr. Beer has also served as the chairman of the board of Origami Surgical LLC since April 2020 and as the chairman of the board of LumeNXT LLC since August 2018. Prior to that, Mr. Beer co-founded Renovia Inc. in August 2016, where he previously held the positions of chairman of the board and chief executive officer and continues to serve as a strategic advisor. Before starting Renovia Inc., Mr. Beer was the chairman of the board of Minerva Neurosciences, Inc. (Nasdaq: NERV) from December 2013 to January 2018. Mr. Beer holds a BS from Miami University.
- Robert Peterson
Robert Peterson自2024年1月起担任百奥泰首席财务官，并于2025年4月起担任首席商务官。在加入Biote之前，Peterson先生曾于2017年9月至2024年1月在全球兽医制药和健康公司Virbac S.A.的子公司Virbac Corp.担任执行副总裁兼首席财务官。Peterson先生是一名注册会计师，拥有得克萨斯基督教大学的学士学位和工商管理硕士学位。
Robert Peterson,has served as the Chief Financial Officer of Biote since January 2024 and also became the Chief Business Officer in April 2025. Prior to joining Biote, Mr. Peterson served as the executive vice president and chief financial officer at Virbac Corp., a subsidiary of Virbac S.A., a global veterinary pharmaceutical and wellness company, from September 2017 to January 2024. Mr. Peterson is a Certified Public Accountant and holds a B.B.A. and an M.B.A. from the Texas Christian University.- Robert Peterson自2024年1月起担任百奥泰首席财务官，并于2025年4月起担任首席商务官。在加入Biote之前，Peterson先生曾于2017年9月至2024年1月在全球兽医制药和健康公司Virbac S.A.的子公司Virbac Corp.担任执行副总裁兼首席财务官。Peterson先生是一名注册会计师，拥有得克萨斯基督教大学的学士学位和工商管理硕士学位。
- Robert Peterson,has served as the Chief Financial Officer of Biote since January 2024 and also became the Chief Business Officer in April 2025. Prior to joining Biote, Mr. Peterson served as the executive vice president and chief financial officer at Virbac Corp., a subsidiary of Virbac S.A., a global veterinary pharmaceutical and wellness company, from September 2017 to January 2024. Mr. Peterson is a Certified Public Accountant and holds a B.B.A. and an M.B.A. from the Texas Christian University.